These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39029371)

  • 1. Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019.
    Bovell-Ammon BJ; Yan S; Dunn D; Evans EA; Friedmann PD; Walley AY; LaRochelle MR
    Drug Alcohol Depend; 2024 Sep; 262():111392. PubMed ID: 39029371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes.
    Bovell-Ammon BJ; Yan S; Dunn D; Evans EA; Friedmann PD; Walley AY; LaRochelle MR
    JAMA Netw Open; 2024 Mar; 7(3):e242732. PubMed ID: 38497959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts.
    Kimmel SD; Walley AY; White LF; Yan S; Grella C; Majeski A; Stein MD; Bettano A; Bernson D; Drainoni ML; Samet JH; Larochelle MR
    JAMA Netw Open; 2024 Jul; 7(7):e2421740. PubMed ID: 39046742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.
    Chatterjee A; Weitz M; Savinkina A; Macmadu A; Madushani RWMA; Potee RA; Ryan D; Murphy SM; Walley AY; Linas BP
    JAMA Netw Open; 2023 Apr; 6(4):e237036. PubMed ID: 37058306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder.
    Bello JK; Xu KY; Salas J; Bedrick BS; Grucza RA
    J Gen Intern Med; 2024 Jun; 39(8):1342-1348. PubMed ID: 38424347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency department utilization by individuals with opioid use disorder who were recently incarcerated.
    Will J; Abare M; Olson M; Chyorny A; Wilhelm-Leen E
    J Subst Abuse Treat; 2022 Oct; 141():108838. PubMed ID: 35868162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and treating incarcerated populations for opioid use disorder.
    Donelan CJ; Hayes E; Potee RA; Schwartz L; Evans EA
    J Subst Abuse Treat; 2021 May; 124():108216. PubMed ID: 33288348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail.
    Bailey A; Senthilkumar R; Evans EA
    J Addict Med; 2023 Sep-Oct 01; 17(5):568-573. PubMed ID: 37788611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.
    O'Reilly LM; Schwartz K; Brown SA; Dir A; Gillenwater L; Adams Z; Zapolski T; Hulvershorn LA; Aalsma M
    Subst Abuse Treat Prev Policy; 2024 Jun; 19(1):32. PubMed ID: 38907286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
    Bagley SM; Larochelle MR; Xuan Z; Wang N; Patel A; Bernson D; Silverstein M; Hadland SE; Land T; Samet JH; Walley AY
    Ann Emerg Med; 2020 Jan; 75(1):29-38. PubMed ID: 31591014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
    Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
    Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications for opioid use disorder during pregnancy: Access and continuity in a state women's prison facility, 2016-2019.
    Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto THM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE
    Drug Alcohol Depend; 2022 Mar; 232():109308. PubMed ID: 35074696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S; Sun L; Vakkalanka JP
    Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
    Cherian T; Lim S; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Rosner Z; MacDonald R; Lee JD
    Drug Alcohol Depend; 2024 Jun; 259():111274. PubMed ID: 38643529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications for opioid use disorder in pregnancy in a state women's prison facility.
    Knittel AK; Zarnick S; Thorp JM; Amos E; Jones HE
    Drug Alcohol Depend; 2020 Sep; 214():108159. PubMed ID: 32683223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.
    Krawczyk N; Lim S; Cherian T; Goldfeld KS; Katyal M; Rivera BD; McDonald R; Khan M; Wiewel E; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Kutscher E; Khatri UG; Rosner Z; Vail WL; MacDonald R; Lee JD
    Drug Alcohol Depend; 2024 Aug; 261():111377. PubMed ID: 38924958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.